Correction: Sepiapterin: A Distinct, Dual Mechanism of Action that Leads to Potential Treatment Benefits Across the Spectrum of Phenylketonuria Disease Severities

Melissa Lah, Jessica Kopesky, Erika Vucko

Open source

DOI
10.1007/s12325-026-03774-2
Published
2026-09-21
Container
Advances in Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03774-2,
  title = {Correction: Sepiapterin: A Distinct, Dual Mechanism of Action that Leads to Potential Treatment Benefits Across the Spectrum of Phenylketonuria Disease Severities},
  author = {Melissa Lah and Jessica Kopesky and Erika Vucko},
  year = {2026},
  journal = {Advances in Therapy},
  doi = {10.1007/s12325-026-03774-2},
  url = {https://doi.org/10.1007/s12325-026-03774-2}
}

RIS

TY  - JOUR
TI  - Correction: Sepiapterin: A Distinct, Dual Mechanism of Action that Leads to Potential Treatment Benefits Across the Spectrum of Phenylketonuria Disease Severities
AU  - Melissa Lah
AU  - Jessica Kopesky
AU  - Erika Vucko
PY  - 2026
JO  - Advances in Therapy
DO  - 10.1007/s12325-026-03774-2
UR  - https://doi.org/10.1007/s12325-026-03774-2
ER  - 

APA

Lah, M., Kopesky, J., & Vucko, E. (2026). Correction: Sepiapterin: A Distinct, Dual Mechanism of Action that Leads to Potential Treatment Benefits Across the Spectrum of Phenylketonuria Disease Severities. Advances in Therapy. https://doi.org/10.1007/s12325-026-03774-2

Source records